Piero Ruggenenti1, Andrea Remuzzi, Giuseppe Remuzzi. Show Affiliations » 1. Mario Negri Institute for Pharmacological Research, Bergamo 24125, Italy.
Abstract
Entities: Disease
Mesh: See more » AnimalsDiabetes Mellitus, Type 1/therapyHumansImmunosuppressive Agents/adverse effectsInsulin/biosynthesisInsulin-Secreting Cells/drug effectsInsulin-Secreting Cells/metabolismInsulin-Secreting Cells/transplantationMiceMice, TransgenicSirolimus/adverse effectsTacrolimus/adverse effects
Substances: See more » Immunosuppressive AgentsInsulinSirolimusTacrolimus
Year: 2008 PMID: 18342671 DOI: 10.1016/S0140-6736(08)60395-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321